Role of FDG PET/CT in Patients With Metastasis of Unknown Origin

Not yet recruitingOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Metastasis
Interventions
DEVICE

PET/CT

"Patient preparation: Patients will fast for 4 - 6 h before PET scanning to optimize the blood sugar level to 160mg/dl. F-18 FDG dose was 0.14 mCi/kg and injected via intravenous route. During the uptake phase of 18F-FDG patients will be rested in a quite warm room.~Procedure:~All PET-CT studies will be done at the nuclear medicine unit in Assuit University Hospital.~PET-CT images will be interpreted at a workstation equipped with fusion software that offers multi-planar reformatted images and enables display of the PET images, CT images, and fused PET/CT images."

All Listed Sponsors
lead

Assiut University

OTHER

NCT06055764 - Role of FDG PET/CT in Patients With Metastasis of Unknown Origin | Biotech Hunter | Biotech Hunter